307 related articles for article (PubMed ID: 16187650)
21. Let's get to work.
Neumann ME
Nephrol News Issues; 2016 Jan; 30(1):8-9. PubMed ID: 26845790
[No Abstract] [Full Text] [Related]
22. Palliative care in patients with CKD.
Szromba C
Nephrol Nurs J; 2007; 34(5):551-2. PubMed ID: 18041458
[No Abstract] [Full Text] [Related]
23. Futuristic plans for ESRD--a new bundled payment system.
Michael M
Nephrol News Issues; 2005 Sep; 19(10):52, 54. PubMed ID: 16187649
[No Abstract] [Full Text] [Related]
24. Conditions for coverage fail to relieve administrative burden.
Wish D
Nephrol News Issues; 2005 Sep; 19(10):46-7, 51. PubMed ID: 16187648
[No Abstract] [Full Text] [Related]
25. The Medicare ESRD program and the U.S. renal community: an all too consistent history.
Sadler JH
Nephrol News Issues; 2003 Mar; 17(4):60-2. PubMed ID: 12696527
[No Abstract] [Full Text] [Related]
26. Predialysis nephrology care and costs in elderly patients initiating dialysis.
Stroupe KT; Fischer MJ; Kaufman JS; O'Hare AM; Sohn MW; Browning MM; Huo Z; Hynes DM
Med Care; 2011 Mar; 49(3):248-56. PubMed ID: 21224743
[TBL] [Abstract][Full Text] [Related]
27. Has the CMS rule of "4 visits per month" influenced patient outcomes? Nephrology healthcare providers should determine the frequency of patient visits.
Larson K
Nephrol Nurs J; 2007; 34(3):343-4. PubMed ID: 17647305
[No Abstract] [Full Text] [Related]
28. The 2011 ESRD prospective payment system: an uncontrolled experiment.
Winkelmayer WC; Chertow GM
Am J Kidney Dis; 2011 Apr; 57(4):542-6. PubMed ID: 21333428
[No Abstract] [Full Text] [Related]
29. The organization of medical care. Lessons from the Medicare end stage renal disease program.
Levinsky NG
N Engl J Med; 1993 Nov; 329(19):1395-9. PubMed ID: 8413437
[No Abstract] [Full Text] [Related]
30. Understanding financial risk models: Implicationsfor nephrology practices and dialysis centers.
Cellini GL
Nephrol News Issues; 2016 Mar; 30(3):26-8, 30-3. PubMed ID: 27169216
[No Abstract] [Full Text] [Related]
31. What can we expect down the road?
Sullivan J
Nephrol News Issues; 2011 Apr; 25(4):28-9. PubMed ID: 21542511
[No Abstract] [Full Text] [Related]
32. Medicare ESRD prospective payment system: weighing the evidence.
Himmelfarb J; Chertow GM
J Am Soc Nephrol; 2005 May; 16(5):1164-5. PubMed ID: 15829705
[No Abstract] [Full Text] [Related]
33. When Congress practices medicine or, where did pete and his colleagues get their medical degrees?
Hull AR
Nephrol News Issues; 1991 Feb; 5(2):14-6. PubMed ID: 1997867
[No Abstract] [Full Text] [Related]
34. The politics of health cost containment: end-stage renal disease.
Rettig RA
Bull N Y Acad Med; 1980; 56(1):115-38. PubMed ID: 6986928
[No Abstract] [Full Text] [Related]
35. Applying the FHN trial results to practice.
Bhat P
Nephrol News Issues; 2011 May; 25(6):24-7. PubMed ID: 21608455
[No Abstract] [Full Text] [Related]
36. Surviving change: Can the ESRD provisions in the SCHIP create a level playing field?
Gardner AV
Nephrol News Issues; 2007 Sep; 21(10):52-3. PubMed ID: 17918480
[No Abstract] [Full Text] [Related]
37. Is bundling the solution for managing the cost of care?
Coutts LR
Nephrol News Issues; 2008 Apr; 22(4):11. PubMed ID: 18488814
[No Abstract] [Full Text] [Related]
38. Impact of HCFA's revised billing instructions for kinetic modeling and recirculation tests.
Rosenthal AF; Mahlke KF
Nephrol News Issues; 1998 Feb; 12(2):12. PubMed ID: 9526364
[No Abstract] [Full Text] [Related]
39. The drug add-on component--have all provider types seen budget neutrality?
Mentz K
Nephrol News Issues; 2005 Sep; 19(10):42-4. PubMed ID: 16187646
[No Abstract] [Full Text] [Related]
40. Who should be paying for vitamin D analogues--Medicare or the patients?
Grotegut J
Nephrol Nurs J; 2006; 33(3):345-6. PubMed ID: 16912996
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
